Skip to content

Public FDA record

Z-0742-2018: Soft-Vu Omni Flush Angiographic Catheter (UPN H787107322015); SV OF 5F x 65 cm .035 NB PG; Catalog Number

Recall record Z-0742-2018 for Angiodynamics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0742-2018
Company in FDA record
Angiodynamics, Inc.
FDA classification date
Feb 13, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product was placed into distribution prior to completion of all required post sterilization release activities.

Source facts

Action
Consignees were contacted by phone and by a letter sent via Federal Express. Consignees were instructed to stop using product, segregate affected product, and return the product to the firm along with a reply verification tracking form. For further questions, please call (518) 795-1676.
Initiated
2017-09-22
Root cause
Process control
Terminated
2018-09-19
Distribution
US Distribution to the states of : AL, CA, CT, FL, GA, IL, IN, MD, MI, MN, MO, OH, OR, TX.
Recall number
Z-0742-2018
Recall status
Terminated
CDRH record ID
161576
FDA classified
2018-02-13
Recall event number
79193

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗